SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-008271
Filing Date
2021-02-11
Accepted
2021-02-11 07:01:58
Documents
69
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1220_inmedpharma.htm 10-Q 552324
2 CERTIFICATION f10q1220ex31-1_inmedpharma.htm EX-31.1 12872
3 CERTIFICATION f10q1220ex31-2_inmedpharma.htm EX-31.2 12837
4 CERTIFICATION f10q1220ex32-1_inmedpharma.htm EX-32.1 3708
5 CERTIFICATION f10q1220ex32-2_inmedpharma.htm EX-32.2 3687
6 GRAPHIC image_001.jpg GRAPHIC 4237
  Complete submission text file 0001213900-21-008271.txt   3020412

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE inm-20201231.xml EX-101.INS 417086
8 XBRL SCHEMA FILE inm-20201231.xsd EX-101.SCH 49054
9 XBRL CALCULATION FILE inm-20201231_cal.xml EX-101.CAL 25207
10 XBRL DEFINITION FILE inm-20201231_def.xml EX-101.DEF 175224
11 XBRL LABEL FILE inm-20201231_lab.xml EX-101.LAB 348525
12 XBRL PRESENTATION FILE inm-20201231_pre.xml EX-101.PRE 188494
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 21616638
SIC: 2834 Pharmaceutical Preparations